$SLXP Company News Drug companies Salix, Inter
Post# of 88791
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Sears leaps on REIT talk; First Solar drops on weak results 10:15 a.m. Nov. 7, 2014 - Sue Chang
Why eBay is like a divorcee, and a pharma pick that’s setting up for a pop 8:45 a.m. Nov. 7, 2014 - Shawn Langlois
Disney’s stock slides as quarterly earnings lack magic 7:04 p.m. Nov. 6, 2014 - Sue Chang
Salix Pharma shares fall on disappointing outlook, CFO resignation 6:54 p.m. Nov. 6, 2014 - Wallace Witkowski
Scuttled ‘inversion’ deals pile up in wake of Treasury rules 3:14 p.m. Oct. 27, 2014 - Robert Schroeder
In focus: Volatility ramps up 5:35 p.m. Oct. 8, 2014 - Lawrence G. McMillan
RadioShack gets a jolt from financing report; Mylan rises 8:22 a.m. Oct. 3, 2014 - Sue Chang
Salix shares jump 5.9% premarket as merger plan is cancelled 7:14 a.m. Oct. 3, 2014 - Silvia Ascarelli
What could scare markets over upcoming earnings, and Buffett’s onto something 6:09 a.m. Oct. 3, 2014 - Barbara Kollmeyer
Salix, Cosmo cancel merger amid inversion crackdown 3:44 a.m. Oct. 3, 2014 - Chip Cummins
Pharma love triangle is a win, win, win for investors 1:11 p.m. Oct. 2, 2014 - The Trading Deck
T. Rowe Price urges Allergan to drop Salix bid 3:38 p.m. Sept. 26, 2014 - Russ Britt
Actavis reportedly in talks to buy Salix Pharma 11:51 a.m. Sept. 24, 2014 - Russ Britt
Actavis's Salix play undermines Allergan defense 11:43 a.m. Sept. 24, 2014 - Russ Britt
Actavis reportedly in talks to buy Salix Pharma 11:42 a.m. Sept. 24, 2014 - Russ Britt
Pershing threatens to sue Allergan if no holder vote held on Salix deal 8:28 a.m. Sept. 23, 2014 - David Benoit
Botox maker Allergan rejected Actavis takeover bid 6:18 p.m. Sept. 22, 2014 - Jonathan D. Rockoff
In focus: Market giving mixed signals 7:02 p.m. Sept. 17, 2014 - Lawrence G. McMillan
'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock? 5:00 a.m. Nov. 8, 2014 - TheStreet.com
Health Sell-Offs Drag On IBD 50 6:31 p.m. Nov. 7, 2014 - Investors Business Daily
Market News: Sears, Salix Pharmaceuticals, Walt Disney 4:38 p.m. Nov. 7, 2014 - TheStreet.com
Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data 4:22 p.m. Nov. 7, 2014 - TheStreet.com
Ackman Calls for Auction of Allergan 3:38 p.m. Nov. 7, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Dow, S&P 500 Give Up Small Gains in Final Hour 3:19 p.m. Nov. 7, 2014 - TheStreet.com
Stock Movers: Why Medicals Issues Are Dipping Today 2:26 p.m. Nov. 7, 2014 - Investors Business Daily
Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, Intercept Pharmaceuticals, Extended Stay America 12:38 p.m. Nov. 7, 2014 - benzinga.com
Salix Pharmaceuticals (SLXP) Earnings Report: Q3 2014 Conference Call Transcript 11:30 a.m. Nov. 7, 2014 - TheStreet.com
Salix Q3 Earnings Marred by Inventory Issues, Cuts View - Analyst Blog 11:09 a.m. Nov. 7, 2014 - Zacks.com
Cramer: Salix Pharmaceuticals' Audit Committee Review Is Concerning 10:54 a.m. Nov. 7, 2014 - TheStreet.com
Jefferies Sees Acquisition Of Salix Pharmaceuticals As Being Even More Likely Now 9:39 a.m. Nov. 7, 2014 - benzinga.com
Benzinga's Top Downgrades 8:56 a.m. Nov. 7, 2014 - benzinga.com
It's going to be ugly for Salix today 8:38 a.m. Nov. 7, 2014 - Seeking Alpha
Today's Pre-Market Mover With Heavy Volume: Salix Pharmaceuticals (SLXP) 7:54 a.m. Nov. 7, 2014 - TheStreet.com
Stifel Nicolaus Downgrades Salix Pharmaceuticals To Hold 7:44 a.m. Nov. 7, 2014 - benzinga.com
Benzinga's Top #PreMarket Losers 7:22 a.m. Nov. 7, 2014 - benzinga.com
UPDATE: Stifel Downgrades Salix Pharmaceuticals As Uncovered Inventories Leaves Many Open Questions 7:15 a.m. Nov. 7, 2014 - benzinga.com
Wall Street Breakfast: Home Depot Says 53M Emails Stolen During Breach 6:30 a.m. Nov. 7, 2014 - Seeking Alpha
10-Q: SALIX PHARMACEUTICALS LTD 6:23 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Salix Pharmaceuticals, Ltd. (SLXP) 11:12 p.m. Nov. 7, 2014 - GlobeNewswire
SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO 10:00 p.m. Nov. 7, 2014 - BusinessWire - BZX
Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd. 8:10 p.m. Nov. 7, 2014 - PR Newswire - PRF
Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws 5:23 p.m. Nov. 7, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Investigation on Behalf of Salix Pharmaceuticals, Ltd. Investors Announced by Law Offices of Howard G. Smith 3:32 p.m. Nov. 7, 2014 - BusinessWire - BZX
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Salix Pharmaceuticals Ltd. - SLXP 3:10 p.m. Nov. 7, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Salix Pharmaceuticals, Ltd. 2:02 p.m. Nov. 7, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Salix Pharmaceuticals Ltd. 1:01 p.m. Nov. 7, 2014 - PR Newswire - PRF
Salix Pharmaceuticals Ltd. Investigated by Block & Leviton LLP After The Company Announces Resignation Of Its Chief Financial Officer And Reduced Financial Forecasts 11:09 a.m. Nov. 7, 2014 - PR Newswire - PRF
Recover Losses: Ademi & O'Reilly, LLP Investigates Possible Securities Fraud of Salix Pharmaceuticals, Ltd. 10:08 a.m. Nov. 7, 2014 - GlobeNewswire
SALIX SHAREHOLDER ALERT: Investor Rights Firm Johnson & Weaver, LLP Announces Investigation of Salix Pharmaceuticals Ltd. 7:20 p.m. Nov. 6, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Reports 3Q2014 Results 4:14 p.m. Nov. 6, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Appoints Acting Chief Financial Officer 4:04 p.m. Nov. 6, 2014 - BusinessWire - BZX
Salix and Pharming Announce the Launch of RUCONEST® in the U.S. for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE) 1:00 a.m. Nov. 3, 2014 - BusinessWire - BZX
Fitch: M&A Premiums Fall on Inversion Crackdown 9:10 a.m. Oct. 27, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Announces 3Q2014 Financial Results Conference Call and Webcast 7:01 a.m. Oct. 23, 2014 - BusinessWire - BZX
New Medicare Plan, Clinical Study Results, ANDA Filing Confirmation, Strategic Collaboration, and Merger Termination - Research Reports on UnitedHealth, Celgene, Actavis, Bristol-Myers Squibb and Salix 9:10 a.m. Oct. 22, 2014 - PR Newswire - PRF
Salix’s TARGET 3 Study Examines the Safety and Efficacy of Repeat Treatment with Rifaximin 550 mg for Irritable Bowel Syndrome with Diarrhea 7:01 a.m. Oct. 21, 2014 - BusinessWire - BZX
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire 8:30 a.m. Oct. 13, 2014 - PR Newswire - PRF
FDA Approves UCERIS® (Budesonide) 2mg Rectal Foam for the Induction of Remission of Mild-to-Moderate Distal Ulcerative Colitis 8:31 a.m. Oct. 8, 2014 - BusinessWire - BZX